Connect your AI

TransMedics Group, Inc. TMDX Price / sales

Price / sales at other companies

LivaNovaLIVN

2.4×+0.8×

ICU MedicalICUI

1.5×+0.1×

Edwards LifesciencesEW

7.3×-0.4×

United TherapeuticsUTHR

8.2×+3.6×

OSI SystemsOSIS

2.4×+0.5×

Other financials

Income statement

Revenue$173.9M+21.2%

Gross profit$101.2M+14.7%

Operating income$13.3M-51.5%

Net income$7.3M-71.5%

EPS (diluted)$0.20-71.4%

Balance sheet

Cash & equivalents$461.7M+48.9%

Total debt$409.9M+505%

Total equity$494.0M+85.5%

Total assets$1.4B+71.3%

Cash flow

Operating cash flow$24.5M+959%

CapEx$36.7M+35.6%

Free cash flow-$12.1M+59.4%

Valuation

Market cap$2.55B+50.6%

Enterprise value$2.5B+66.0%

P/E14.8×-19.8×

Profitability

Gross margin59.1%-0.4pp

Operating margin14.9%+4.1pp

Net margin27%+17.0pp

FCF margin23.8%—

Returns & leverage

Return on equity45.2%+22.2pp

Debt / equity0.8×+0.6×

Current ratio6.7×-2.4×

Where this comes from

Calculated from TransMedics Group, Inc.’s reported figures.

market cap/total revenue=5.4×

Based on the most recent quarter.

The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransMedics Group, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is TransMedics Group, Inc.'s price / sales?: TransMedics Group, Inc. (TMDX) reported price / sales of 5.4× in Q1 2026.
How has TransMedics Group, Inc.'s price / sales changed year-over-year?: TransMedics Group, Inc.'s price / sales increased by 15.6% year-over-year, from 4.6× to 5.4×.
What is the long-term trend for TransMedics Group, Inc.'s price / sales?: Over 5 years (2020 to 2025), TransMedics Group, Inc.'s price / sales has grown at a -20.4% compound annual growth rate (CAGR), from 21.6× to 6.9×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.